Ayahuasca: Difference between revisions

>Tracer
Added link to Bluelight
>David Hedlund
===Potential antidepressant effects=== PMID: 29903051, https://clinicaltrials.gov/ct2/show/NCT02914769
Line 175: Line 175:
===Potential antidepressant effects===
===Potential antidepressant effects===
A 2015 preliminary report has found a significant reduction of up to 82% in depressive scores following ayahuasca administration.<ref>Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report - http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462015000100013&lng=en&nrm=iso&tlng=en</ref> The report concludes that "these results suggest that [ayahuasca] has fast-acting anxiolytic and antidepressant effects in patients with a depressive disorder." Its acute and fast-acting effects show promise for the treatment of depression as common antidepressants, such as fluoxetine (Prozac), take weeks to show significant effects and are simply ineffective for many users.
A 2015 preliminary report has found a significant reduction of up to 82% in depressive scores following ayahuasca administration.<ref>Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report - http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462015000100013&lng=en&nrm=iso&tlng=en</ref> The report concludes that "these results suggest that [ayahuasca] has fast-acting anxiolytic and antidepressant effects in patients with a depressive disorder." Its acute and fast-acting effects show promise for the treatment of depression as common antidepressants, such as fluoxetine (Prozac), take weeks to show significant effects and are simply ineffective for many users.
A 2016 placebo randomized controlled trial evaluated the rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression with positive outcome.<ref>{{cite journal |last1=Palhano-Fontes |first1=F |last2=Barreto |first2=D |last3=Onias |first3=H |last4=Andrade |first4=KC |last5=Novaes |first5=MM |last6=Pessoa |first6=JA |last7=Mota-Rolim |first7=SA |last8=Osório |first8=FL |last9=Sanches |first9=R |last10=Dos Santos |first10=RG |last11=Tófoli |first11=LF |last12=de Oliveira Silveira |first12=G |last13=Yonamine |first13=M |last14=Riba |first14=J |last15=Santos |first15=FR |last16=Silva-Junior |first16=AA |last17=Alchieri |first17=JC |last18=Galvão-Coelho |first18=NL |last19=Lobão-Soares |first19=B |last20=Hallak |first20=JEC |last21=Arcoverde |first21=E |last22=Maia-de-Oliveira |first22=JP |last23=Araújo |first23=DB |title=Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. |journal=Psychological medicine |date=March 2019 |volume=49 |issue=4 |pages=655-663 |doi=10.1017/S0033291718001356 |pmid=29903051}}</ref><ref>{{cite web |title=Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression - Full Text View - ClinicalTrials.gov |url=https://clinicaltrials.gov/ct2/show/NCT02914769 |website=clinicaltrials.gov |language=en}}</ref>


The mechanism by which ayahuasca produces antidepressant effects is not well known, but studies have hypothesized that the MAO-inhibitor and weak [[serotonin]] [[reuptake inhibitor]] effects of ayahuasca alkaloids may be of relevance. Research on the antidepressant potential of [[psilocin]] suggests that the subjective effects of 5-HT<sub>2A</sub> agonism also contribute to antidepressant effects, but further research is required to understand the effects of psychedelic drugs on depressive disorders.
The mechanism by which ayahuasca produces antidepressant effects is not well known, but studies have hypothesized that the MAO-inhibitor and weak [[serotonin]] [[reuptake inhibitor]] effects of ayahuasca alkaloids may be of relevance. Research on the antidepressant potential of [[psilocin]] suggests that the subjective effects of 5-HT<sub>2A</sub> agonism also contribute to antidepressant effects, but further research is required to understand the effects of psychedelic drugs on depressive disorders.